Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Context: Children with autism spectrum disorder (ASD) frequently use special diets or receive nutritional supplements to treat ASD symptoms.

Objectives: Our objective was to evaluate the effectiveness and safety of dietary interventions or nutritional supplements in ASD.

Data Sources: Databases, including Medline and PsycINFO.

Study Selection: Two investigators independently screened studies against predetermined criteria.

Data Extraction: One investigator extracted data with review by a second investigator. Investigators independently assessed the risk of bias and strength of evidence (SOE) (ie, confidence in the estimate of effects).

Results: Nineteen randomized controlled trials (RCTs), 4 with a low risk of bias, evaluated supplements or variations of the gluten/casein-free diet and other dietary approaches. Populations, interventions, and outcomes varied. Ω-3 supplementation did not affect challenging behaviors and was associated with minimal harms (low SOE). Two RCTs of different digestive enzymes reported mixed effects on symptom severity (insufficient SOE). Studies of other supplements (methyl B, levocarnitine) reported some improvements in symptom severity (insufficient SOE). Studies evaluating gluten/casein-free diets reported some parent-rated improvements in communication and challenging behaviors; however, data were inadequate to make conclusions about the body of evidence (insufficient SOE). Studies of gluten- or casein-containing challenge foods reported no effects on behavior or gastrointestinal symptoms with challenge foods (insufficient SOE); 1 RCT reported no effects of camel's milk on ASD severity (insufficient SOE). Harms were disparate.

Limitations: Studies were small and short-term, and there were few fully categorized populations or concomitant interventions.

Conclusions: There is little evidence to support the use of nutritional supplements or dietary therapies for children with ASD.

Download full-text PDF

Source
http://dx.doi.org/10.1542/peds.2017-0346DOI Listing

Publication Analysis

Top Keywords

insufficient soe
20
nutritional supplements
12
severity insufficient
12
soe studies
12
dietary interventions
8
autism spectrum
8
spectrum disorder
8
investigators independently
8
risk bias
8
challenging behaviors
8

Similar Publications

Space-charge-limited current (SCLC) analysis is widely employed to extract trap densities and carrier mobility in perovskite materials. However, its validity in multilayer perovskite devices, such as those incorporating charge-transporting layers (CTLs), has remained insufficiently examined. Moreover, coupled electronic-ionic charge transport in perovskite materials, where mobile ions act as free carrier traps, remains incompletely understood.

View Article and Find Full Text PDF

Objective: To enhance the quality of care and clinical outcomes for adolescents with Substance use disorder (SUD) and problematic substance use (PSU). The aims are twofold: 1) to summarize empirically-based guidance about the psychosocial, behavioral, and psychopharmacologic treatment of SUDs and PSU in adolescents and young adults; and 2) to summarize expert-based guidance about the assessment and clinical management of these disorders.

Method: Statements about the treatment of SUD / PSU are based upon empirical evidence derived from a critical systematic review of the scientific literature conducted by the Brown Evidence-Based Practice Center under contract with the Agency for Healthcare Research and Quality (AHRQ).

View Article and Find Full Text PDF

Background: Unconditional cash transfers (UCTs) through social programs or direct cash transfers (DCTs) may address drivers of pregnancy-related morbidity and mortality.

Purpose: To summarize evidence on UCTs and postpartum outcomes in the United States.

Data Sources: PubMed, Embase, Web of Science, Social Science Research Network, and structured internet searches through 28 January 2025.

View Article and Find Full Text PDF

Background: Patients with chronic kidney disease (CKD) are at increased risk of ischemic stroke (IS) and intracerebral hemorrhage, so the safety and efficacy of early direct oral anticoagulant (DOAC) initiation in those with CKD are of clinical relevance.

Methods: OPTIMAS (Optimal Timing of Anticoagulation After Acute Ischemic Stroke With Atrial Fibrillation) was a multicenter, randomized, parallel-group, open-label trial with blinded outcome assessment, recruiting patients with IS and atrial fibrillation from 100 UK hospitals between 2019 and 2024. Participants were randomized 1:1, stratified by stroke severity, to early (within 4 days of onset) or delayed (at days 7-14) DOAC initiation.

View Article and Find Full Text PDF